Utah Medical Products, Inc. (UTMD)
NASDAQ: UTMD · Real-Time Price · USD
64.25
-1.52 (-2.31%)
May 4, 2026, 12:54 PM EDT - Market open

Utah Medical Products Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
87.4185.7682.9892.8775.0560.97
Cash & Short-Term Investments
87.4185.7682.9892.8775.0560.97
Cash Growth
4.90%3.35%-10.65%23.74%23.09%18.19%
Accounts Receivable
3.643.524.093.395.545.13
Inventory
8.727.948.819.588.816.6
Other Current Assets
0.610.530.450.430.520.46
Total Current Assets
100.3897.7496.33106.2789.9273.16
Net Property, Plant & Equipment
9.729.919.7610.5510.2210.62
Other Intangible Assets
-0.842.874.9510.3817.76
Goodwill
-14.0513.5813.6913.3514.1
Total Assets
124.38122.54122.54135.46123.87115.64
Accounts Payable
1.190.910.70.771.220.76
Accrued Expenses
2.311.693.063.944.742.98
Total Current Liabilities
3.512.63.764.715.963.75
Long-Term Leases
0.210.230.280.30.340.4
Other Long-Term Liabilities
0.290.451.072.143.324.36
Total Long-Term Liabilities
0.50.681.352.443.664.75
Total Liabilities
4.013.275.117.159.628.5
Common Stock
-0.030.030.040.040.04
Additional Paid-in Capital
---0.590.250.84
Accumulated Other Comprehensive Income
--9.42-11.91-10.66-12.04-9.05
Retained Earnings
-128.65129.3138.34126.01115.31
Shareholders' Equity
-119.27117.43128.31114.25107.14
Total Liabilities & Equity
124.38122.54122.54135.46123.87115.64
Total Debt
0.210.230.280.30.340.4
Net Cash (Debt)
87.285.5382.6992.5774.7160.58
Net Cash Growth
1.95%3.43%-10.67%23.91%23.33%18.19%
Net Cash Per Share
27.1726.4023.6125.4520.5116.55
Book Value
-119.27117.43128.31114.25107.14
Book Value Per Share
-36.8133.5235.2831.3629.27
Tangible Book Value
-104.38100.98109.6890.5275.28
Tangible Book Value Per Share
-32.2128.8330.1624.8520.57
Updated Mar 31, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q